Program
sildenafil
Also written as “Sildenafil”, “Sildenafil citrate” and “sildenafil citrate”.
Its studies are mostly in Erectile Dysfunction · Pulmonary Arterial Hypertension · Hypertension, Pulmonary · Sexual Dysfunctions, Psychological · Persistent Fetal Circulation Syndrome, led by 10 companies.
Drug pageSildenafil: every studyMany companies study it; this page follows only the 60 they lead. All 330 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Viatrisits history only | 470 open or running | phase 4since Aug 26, 2005 | Aug 26, 2005 | none ahead |
| Strategic Science & Technologiesits history only | 40 open or running | phase 2since Mar 9, 2015 | Oct 29, 2013 | none ahead |
| Hanmi Pharmaceuticalits history only | 20 open or running | phase 3since Jul 30, 2013 | Jan 18, 2012 | none ahead |
| Daré Bioscienceits history only | 10 open or running | phase 1since Mar 1, 2023 | Mar 1, 2023 | none ahead |
| Emotional Brain NYits history only | 10 open or running | phase 2since Aug 17, 2011 | Aug 17, 2011 | none ahead |
| Hamad Medicalits history only | 10 open or running | phase 3since Mar 11, 2012 | Mar 11, 2012 | none ahead |
| Hoffmann-La Rocheits history only | 10 open or running | phase 2since Oct 28, 2016 | Oct 28, 2016 | none ahead |
| Laboratório Teuto Brasileiro S/Aits history only | 10 open or running | phase 3since Mar 15, 2011 | Mar 15, 2011 | none ahead |
| N4 Pharma UKits history only | 10 open or running | phase 1since Apr 12, 2018 | Apr 12, 2018 | none ahead |
| Pharmtechnologyits history only | 10 open or running | phase 1since May 6, 2021 | May 6, 2021 | none ahead |
Also a collaborator on its studies: Pfizer, BDD Pharma and ICOS.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of every company. Pick one to see its own:
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 45 studies since Aug 26, 2005.
- Mar 11, 2012Hamad Medical’s first study: phase 3 study in Persistent Fetal Circulation SyndromeNew to Hamad MedicalHamad Medical · NCT01558466 · 100 enrolled · Qatar
- Jun 15, 2012Phase 4 study in Pulmonary Arterial HypertensionViatris · NCT01642407 · 6 enrolled · Japan
- Aug 1, 20122 phase 1 studies in HealthyViatris · NCT01656798, NCT01737203
- Sep 17, 2012Phase 3 study in Persistent Fetal Circulation SyndromeViatris · NCT01720524 · 59 enrolled · United States, Belgium, Canada and more
- Jul 30, 2013Phase 3 study in Hypertension, PulmonaryHanmi Pharmaceutical · NCT01913847 · 144 enrolled · Korea, Republic of
- Oct 29, 2013Strategic Science & Technologies’ first study: phase 1 study in HealthyNew to Strategic Science & TechnologiesStrategic Science & Technologies · NCT01986673 · 62 enrolled · United States
- Jan 29, 2014Phase 4 study in Pulmonary Arterial HypertensionViatris · NCT02060487 · 385 enrolled · United States, Australia, Belgium and more
- Jan 27, 2015Phase 1 study in Female Sexual HealthStrategic Science & Technologies · NCT02364882 · 21 enrolled · United States
- Mar 9, 2015Phase 2 study in Erectile DysfunctionStrategic Science & Technologies · NCT02390960 · 33 enrolled · United States
- Oct 28, 2016Hoffmann-La Roche’s first study: phase 2 study in Idiopathic Pulmonary FibrosisNew to Hoffmann-La RocheHoffmann-La Roche · NCT02951429 · 177 enrolled · Belgium, Canada, Czechia and more
- Apr 12, 2018N4 Pharma UK’s first study: phase 1 study in Erectile DysfunctionNew to N4 Pharma UKN4 Pharma UK · NCT03510338 · 12 enrolled · United Kingdom
- May 6, 2021Pharmtechnology’s first study: phase 1 study in BioequivalenceNew to PharmtechnologyPharmtechnology · NCT04882826 · 44 enrolled · Russian Federation
- Jun 24, 2021Phase 2 study in Sexual Dysfunction, PhysiologicalStrategic Science & Technologies · NCT04948151 · 440 enrolled · United States
- Mar 1, 2023Daré Bioscience’s first study: phase 1 study in Sexual Dysfunctions, PsychologicalNew to Daré BioscienceDaré Bioscience · NCT05765487 · 13 enrolled · Canada
TargetBeta
“Phosphodiesterase 5A inhibitor”ChEMBL 37, by rule
Other programs on PDE5A
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| Tadalafilrule | Eli Lilly | phase 4 | 73 |
Studies
All 60 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT05765487Sexual Dysfunctions, Psychological · Canada | 1 | Completed | Daré Bioscience | Jan 26, 2024 | 13 |
| NCT04948151Sexual Dysfunction, Physiological · United States | 2 | UNKNOWN | Strategic Science & Technologies | Dec 15, 2021 | 440 |
| NCT04882826Bioequivalence · Russian Federation | 1 | UNKNOWN | Pharmtechnology | May 30, 2021 | 44 |
| NCT03510338Erectile Dysfunction · United Kingdom | 1 | Completed | N4 Pharma UK | Jun 13, 2018 | 12 |
| NCT02951429Idiopathic Pulmonary Fibrosis · Belgium, Canada, Czechia and more | 2 | Completed | Hoffmann-La Roche | Sep 26, 2019 | 177 |
| NCT02390960Erectile Dysfunction · United States | 2 | Completed | Strategic Science & Technologies | Apr 2017 | 33 |
| NCT02364882Female Sexual Health · United States | 1 | Completed | Strategic Science & Technologies | May 2015 | 21 |
| NCT02060487Pulmonary Arterial Hypertension · United States, Australia, Belgium and more | 4 | Terminated | Viatris | Feb 26, 2021 | 385 |
| NCT01986673Healthy · United States | 1 | Completed | Strategic Science & Technologies | Nov 2013 | 62 |
| NCT01913847Hypertension, Pulmonary · Korea, Republic of | 3 | UNKNOWN | Hanmi Pharmaceutical | Dec 2018 | 144 |
| NCT01720524Persistent Fetal Circulation Syndrome · United States, Belgium, Canada and more | 3 | Completed | Viatris | Oct 17, 2018 | 59 |
| NCT01737203Healthy · Japan | 1 | Completed | Viatris | Sep 2012 | 53 |
| NCT01656798Healthy · Singapore | 1 | Completed | Viatris | Aug 2012 | 12 |
| NCT01642407Pulmonary Arterial Hypertension · Japan | 4 | Completed | Viatris | May 20, 2016 | 6 |
| NCT01558466Persistent Fetal Circulation Syndrome · Qatar | 3 | UNKNOWN | Hamad Medical | Nov 2014 | 100 |
| NCT01514903Erectile Dysfunction · Korea, Republic of | 1 | Completed | Hanmi Pharmaceutical | Dec 2011 | 54 |
| NCT01432665Sexual Dysfunctions, Psychological · United States | 2 | Completed | Emotional Brain NY | May 2013 | 196 |
| NCT01360671Persistent Fetal Circulation Syndrome | 2 | Withdrawn | Viatris | Apr 2013 | 0 |
| NCT01321489Erectile Dysfunction · Brazil | 3 | UNKNOWN | Laboratório Teuto Brasileiro S/A | Jan 2012 | 78 |
| NCT01247805Pulmonary Arterial Hypertention · Belgium | 1 | Completed | Viatris | Feb 2011 | 42 |
| NCT01254396Erectile Dysfunction · Singapore | 1 | Completed | Viatris | Jan 2011 | 12 |
| NCT01254383Erectile Dysfunction · Singapore | 1 | Completed | Viatris | Mar 2011 | 36 |
| NCT01027117Healthy · Belgium | 1 | Completed | Viatris | Sep 2009 | 18 |
| NCT00904748Erectile Dysfunction · Brazil | 1 | Completed | Viatris | Mar 2010 | 47 |
| NCT00866463Erectile Dysfunction · United States | 1 | Completed | Viatris | Oct 2008 | 18 |
| NCT00800592Hypertension, Pulmonary · Belgium | 1 | Completed | Viatris | Dec 2008 | 12 |
| NCT00795938Erectile Dysfunction · United States | 1 | Completed | Viatris | Nov 2008 | 18 |
| NCT00746967Sexual Dysfunctions, Psychological · United States | 2 | Completed | Viatris | 267 | |
| NCT00654082Spinal Cord Injuries · Turkey | 4 | Completed | Viatris | 88 | |
| NCT00654017Erectile Disfunction · Brazil | 4 | Completed | Viatris | 100 | |
| NCT00648596Erectile Dysfunction · Finland, France, Italy and more | 4 | Completed | Viatris | 780 | |
| NCT00644956Erectile Dysfunction · Norway, United Kingdom | 4 | Completed | Viatris | 56 | |
| NCT00644631Erectile Dysfunction · United States | 4 | Completed | Viatris | 300 | |
| NCT00645268Erectile Dysfunction · United States, Canada | 4 | Completed | Viatris | 300 | |
| NCT00645034Prostatic Hyperplasia · United States | 2 | Completed | Viatris | 20 | |
| NCT00644605Hypertension, Pulmonary · United States, Australia, Belgium and more | 3 | Completed | Viatris | 275 | |
| NCT00640458Female Sexual Arousal Disorder · United States, Australia | 2 | Completed | Viatris | 20 | |
| NCT00468650Erectile Dysfunction · Mexico | 4 | Completed | Viatris | Feb 2008 | 117 |
| NCT00454207Hypertension, Pulmonary · Japan | 3 | Completed | Viatris | Feb 2009 | 44 |
| NCT00430716Pulmonary Arterial Hypertension · United States, Belgium, Brazil and more | 4 | Terminated | Viatris | May 25, 2010 | 130 |
| NCT00343200Erectile Dysfunction · United States | 4 | Completed | Viatris | 371 | |
| NCT00323297Pulmonary Arterial Hypertension · United States, Australia, Czechia and more | 4 | Completed | Viatris | Aug 2013 | 105 |
| NCT00301262Erectile Dysfunction · Canada | 4 | Completed | Viatris | Sep 2007 | 183 |
| NCT00249730Erectile Dysfunction · Canada, France, Greece and more | 4 | Completed | Viatris | 510 | |
| NCT00245596Erectile Dysfunction · France | 4 | Completed | Viatris | 120 | |
| NCT00245258Erectile Dysfunction · Korea, Republic of, Russian Federation, Spain and more | 4 | Completed | Viatris | 312 | |
| NCT00159913Pulmonary Arterial Hypertension · United States, Brazil, Canada and more | 3 | Completed | Viatris | Jun 2008 | 235 |
| NCT00159900Erectile Dysfunction · Brazil, Germany, Italy and more | 4 | Completed | Viatris | 300 | |
| NCT00159887Hypertension, Pulmonary · United States, Australia, Belgium and more | 3 | Completed | Viatris | 260 | |
| NCT00159874Pulmonary Arterial Hypertension · United States, Brazil, Chile and more | 3 | Completed | Viatris | Dec 2012 | 234 |
| NCT00159861Hypertension, Pulmonary · United States, Belgium, Canada and more | 3 | Completed | Viatris | 267 | |
| NCT00159809Erectile Dysfunction | 4 | Completed | Viatris | 140 | |
| NCT00151463Erectile Dysfunction · Australia | 4 | Completed | Viatris | 100 | |
| NCT00150358Erectile Dysfunction · Mexico | 4 | Completed | Viatris | 253 | |
| NCT00147628Erectile Dysfunction · United States | 4 | Completed | Viatris | 209 | |
| NCT00145483Meniere Disease · Australia | 4 | Completed | Viatris | Nov 8, 2006 | 163 |
| NCT00143260Erectile Dysfunction · United States | 4 | Completed | Viatris | May 2006 | 250 |
| NCT00143221Erectile Dysfunction | 4 | Completed | Viatris | 350 | |
| NCT00141310Pre-Eclampsia · United Kingdom | 2 | Terminated | Viatris | 76 | |
| NCT00137072Erectile Dysfunction · United States | 4 | Completed | Viatris | 355 |
How it is read
Names in the registry
- “Sildenafil”, 27 entries
- “sildenafil”, 18 entries
- “Sildenafil citrate”, 14 entries
- “sildenafil citrate”, 10 entries
- “Sildenafil Citrate”, 4 entries
Conditions, from the studies’ own filings
- Erectile Dysfunction, 33 studies
- Pulmonary Arterial Hypertension, 11 studies
- Hypertension, Pulmonary, 6 studies
- Sexual Dysfunctions, Psychological, 3 studies
- Persistent Fetal Circulation Syndrome, 3 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.